New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
10:25 EDTDRRX, DRRX, PCRX, PCRXSummer Street's chief scientific officer holds analyst/industry conference call
Chief Scientific Officer Classen discusses Durect's (DRRX) Posidur for post-operative pain, its safety and whether it could be disruptive to Pacira Pharmaceuticals (PCRX) on an Analyst/Industry conference call to be held on January 8 at 11 am.
News For DRRX;PCRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 16, 2014
16:30 EDTPCRXAratana Therapeutics initiates pivotal study for AT-003
Subscribe for More Information
08:04 EDTDRRXDURECT grants Santen worldwide rights to sustained release SABER
Subscribe for More Information
06:36 EDTDRRXDURECT initiated with a Hold at Cantor
Subscribe for More Information
December 12, 2014
08:33 EDTPCRXPacira announces FDA approves changes to EXPAREL label
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use